文献速递糖尿病

俄勒冈州医疗补助扩展后糖尿病成人医疗支出趋势

Health Care Expenditures Among Adults With Diabetes After Oregon's Medicaid Expansion.
PubMed 文献 · Diabetes Care · 2019-12-19

该研究利用俄勒冈州医疗补助行政数据,回顾性比较ACA扩展后新符合资格与先前符合资格的糖尿病成人医疗补助支出趋势。新符合资格者初始月度人均支出显著较低(561美元 vs 793美元,P=0.018),随后三个季度内升至略低水平,之后两组均持续上升,新符合资格者支出增长主要源于处方药支出快速增加。

要点

  • 新符合资格糖尿病患者的初始月度人均医疗补助支出显著低于先前符合资格者。
  • 新符合资格者支出在扩展后三个季度内升至与先前符合资格者相似但略低的水平。
  • 新符合资格者总支出增长主要归因于处方药支出的快速上升。

核心结论

  • 新符合资格医疗补助的糖尿病参保者月度人均支出略低于先前符合资格者。
  • 处方药支出增加提示随着时间推移治疗可及性提高。

研究设计与样本

  • 利用俄勒冈州2014年1月1日至2016年9月30日医疗补助行政数据开展回顾性队列研究。
  • 采用倾向评分匹配新符合资格与先前符合资格的医疗补助资格组。

主要发现

  • 扩展后第一个季度,新符合资格者月度人均总支出为561美元,匹配的先前符合资格者为793美元(P=0.018)。
  • 扩展后前三个季度内,新符合资格者月度人均支出升至相似但略低水平,之后两组均持续上升。
  • 新符合资格者总月度人均支出增长大部分源于处方药支出快速增加。

临床怎么用

  • 关注新扩展医疗补助的糖尿病患者处方药支出增长趋势,提示治疗可及性改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare trends in Medicaid expenditures among adults with diabetes who were newly eligible due to the Affordable Care Act (ACA) Medicaid expansion to trends among those previously eligible. RESEARCH DESIGN AND METHODS: Using Oregon Medicaid administrative data from 1 January 2014 to 30 September 2016, a retrospective cohort study was conducted with propensity score-matched Medicaid eligibility groups (newly and previously eligible). Outcome measures included total per-member per-month (PMPM) Medicaid expenditures and PMPM expenditures in the following 12 categories: inpatient visits, emergency department visits, primary care physician visits, specialist visits, prescription drugs, transportation services, tests, imaging and echography, procedures, durable medical equipment, evaluation and management, and other or unknown services. RESULTS: Total PMPM Medicaid expenditures for newly eligible enrollees with diabetes were initially considerably lower compared with PMPM expenditures for matched previously eligible enrollees during the first postexpansion quarter (mean values $561 vs. $793 PMPM, P = 0.018). Within the first three postexpansion quarters, PMPM expenditures of the newly eligible increased to a similar but slightly lower level. Afterward, PMPM expenditures of both groups continued to increase steadily. Most of the overall PMPM expenditure increase among the newly eligible was due to rapidly increasing prescription drug expenditures. CONCLUSIONS: Newly eligible Medicaid enrollees with diabetes had slightly lower PMPM expenditures than previously eligible Medicaid enrollees. The increase in PMPM prescription drug expenditures suggests greater access to treatment over time.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lindner SR, Marino M, O'Malley J, et al. Health Care Expenditures Among Adults With Diabetes After Oregon's Medicaid Expansion. Diabetes Care. 2019. PMID: 31857442. doi:10.2337/dc19-1343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。